IBDEI1IW ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25454,0)
 ;;=B00.1^^124^1247^43
 ;;^UTILITY(U,$J,358.3,25454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25454,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,25454,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,25454,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,25455,0)
 ;;=A60.01^^124^1247^44
 ;;^UTILITY(U,$J,358.3,25455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25455,1,3,0)
 ;;=3^Herpetic Infect of Penis
 ;;^UTILITY(U,$J,358.3,25455,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,25455,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,25456,0)
 ;;=A60.04^^124^1247^45
 ;;^UTILITY(U,$J,358.3,25456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25456,1,3,0)
 ;;=3^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,25456,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,25456,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,25457,0)
 ;;=Z21.^^124^1247^33
 ;;^UTILITY(U,$J,358.3,25457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25457,1,3,0)
 ;;=3^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,25457,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,25457,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,25458,0)
 ;;=B20.^^124^1247^32
 ;;^UTILITY(U,$J,358.3,25458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25458,1,3,0)
 ;;=3^HIV + (Symptomatic)/AIDS
 ;;^UTILITY(U,$J,358.3,25458,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,25458,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,25459,0)
 ;;=A63.0^^124^1247^47
 ;;^UTILITY(U,$J,358.3,25459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25459,1,3,0)
 ;;=3^Human Papillomavirus infection
 ;;^UTILITY(U,$J,358.3,25459,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,25459,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,25460,0)
 ;;=T85.79XA^^124^1247^48
 ;;^UTILITY(U,$J,358.3,25460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25460,1,3,0)
 ;;=3^Infect/inflm reaction d/t implantable device graft,init encntr
 ;;^UTILITY(U,$J,358.3,25460,1,4,0)
 ;;=4^T85.79XA
 ;;^UTILITY(U,$J,358.3,25460,2)
 ;;=^5055676
 ;;^UTILITY(U,$J,358.3,25461,0)
 ;;=J11.00^^124^1247^60
 ;;^UTILITY(U,$J,358.3,25461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25461,1,3,0)
 ;;=3^Influenza with unspecified type of pneumonia
 ;;^UTILITY(U,$J,358.3,25461,1,4,0)
 ;;=4^J11.00
 ;;^UTILITY(U,$J,358.3,25461,2)
 ;;=^5008156
 ;;^UTILITY(U,$J,358.3,25462,0)
 ;;=H83.09^^124^1247^61
 ;;^UTILITY(U,$J,358.3,25462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25462,1,3,0)
 ;;=3^Labyrinthitis, NOS
 ;;^UTILITY(U,$J,358.3,25462,1,4,0)
 ;;=4^H83.09
 ;;^UTILITY(U,$J,358.3,25462,2)
 ;;=^5006897
 ;;^UTILITY(U,$J,358.3,25463,0)
 ;;=H83.02^^124^1247^63
 ;;^UTILITY(U,$J,358.3,25463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25463,1,3,0)
 ;;=3^Labyrinthitis, left ear
 ;;^UTILITY(U,$J,358.3,25463,1,4,0)
 ;;=4^H83.02
 ;;^UTILITY(U,$J,358.3,25463,2)
 ;;=^5006895
 ;;^UTILITY(U,$J,358.3,25464,0)
 ;;=H83.01^^124^1247^64
 ;;^UTILITY(U,$J,358.3,25464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25464,1,3,0)
 ;;=3^Labyrinthitis, right ear
 ;;^UTILITY(U,$J,358.3,25464,1,4,0)
 ;;=4^H83.01
 ;;^UTILITY(U,$J,358.3,25464,2)
 ;;=^5006894
 ;;^UTILITY(U,$J,358.3,25465,0)
 ;;=H83.03^^124^1247^62
 ;;^UTILITY(U,$J,358.3,25465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25465,1,3,0)
 ;;=3^Labyrinthitis, bilateral
 ;;^UTILITY(U,$J,358.3,25465,1,4,0)
 ;;=4^H83.03
 ;;^UTILITY(U,$J,358.3,25465,2)
 ;;=^5006896
 ;;^UTILITY(U,$J,358.3,25466,0)
 ;;=A48.1^^124^1247^66
 ;;^UTILITY(U,$J,358.3,25466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25466,1,3,0)
 ;;=3^Legionella pneumonia/Legionnnaire's
 ;;^UTILITY(U,$J,358.3,25466,1,4,0)
 ;;=4^A48.1
 ;;^UTILITY(U,$J,358.3,25466,2)
 ;;=^68817
 ;;^UTILITY(U,$J,358.3,25467,0)
 ;;=A69.20^^124^1247^67
